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Abstract Extracellular nucleotides mediate glia-to-neuron
signalling in the retina and are implicated in the volume
regulation of retinal glial (Müller) cells under osmotic stress
conditions.We investigatedthe expressionandfunctionalrole
of ectonucleotidases in Müller cells of the rodent retina by
cell-swelling experiments, calcium imaging, and immuno-
and enzyme histochemistry. The swelling of Müller cells
under hypoosmotic stress was inhibited by activation of an
autocrine purinergic signalling cascade. This cascade is
initiated by exogenous glutamate and involves the consecu-
tive activation of P2Y1 and adenosine A1 receptors, the
action of ectoadenosine 5′-triphosphate (ATP)ases, and a
nucleoside-transporter-mediated release of adenosine. Inhibi-
tion of ectoapyrases increased the ATP-evoked calcium
responses in Müller cell endfeet. Müller cells were immu-
noreactive for nucleoside triphosphate diphosphohydrolases
(NTPDase)2 (but not NTPDase1), ecto-5′-nucleotidase,
P2Y1, and A1 receptors. Enzyme histochemistry revealed
that ATP but not adenosine 5′-diphosphate (ADP) is
extracellularly metabolised in retinal slices of NTPDase1
knockout mice. NTPDase1 activity and protein is restricted
to blood vessels, whereas activity of alkaline phosphatase is
essentially absent at physiological pH. The data suggest that
NTPDase2 is the major ATP-degrading ectonucleotidase of
the retinal parenchyma. NTPDase2 expressed by Müller cells
can be implicated in the regulation of purinergic calcium
responses and cellular volume.
Keywords A1receptor.Cellularswelling.
Ectonucleotidase.Müllerglialcell.P2receptor.Retina
Introduction
Glial cells play an active role in the regulation of neuronal
activity. By release of so-called gliotransmitters, in particular
glutamate and adenosine 5′-triphosphate (ATP), activated
glial cells provide both excitatory and inhibitory effects on
neighbouring neurons. Excitation is mediated predominantly
by glutamate, whereas ATP, after extracellular conversion to
adenosine, causes neuronal suppression [1–3]. In the neural
retina, stimulation of Müller glial cells by receptor agonists
such as ATP, dopamine and thrombin, or electrical and
mechanical stimuli, triggers intracellular calcium responses
associated with a release of ATP from the cells [4, 5]. It has
been suggested that ATP released from Müller cells is
extracellularly converted to adenosine, which in turn
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resulting in cellular hyperpolarisation [5]. In addition to the
involvement in glia-to-neuron signalling, glia-derived
nucleotides in the retina have autocrine effects. ATP
released from retinal glial cells and subsequent activation
of purinergic receptors evokes long-range calcium waves in
the glial cell network [4] and inhibits the swelling of Müller
cells under conditions of osmotic stress [6].
ExtracellularmetabolismofATPhasbeenimplicatedinthe
glia-to-neuron signalling in the retina [5]. It is known that
Müller cells express ecto-5′-nucleotidase (CD73) [7–9], at
least during the period of postnatal vasculogenesis [10].
CD73 hydrolyses nucleoside monophosphates such as AMP
to the respective nucleosides [11]. However, it is unclear
whether Müller cells also express ectoenzymes that degrade
ATP, such as nucleoside triphosphate diphosphohydrolases
(NTPDases) or ectonucleotide pyrophosphatase/phospho-
diesterases (ENPPs). NTPDase1 (CD39, ectoapyrase) and
NTPDase2 (CD39L1, ecto-ATPase), as well as NTPDases 3
and 8, are capable of hydrolysing nucleoside 5′-tri- and
diphosphates such as ATP and ADP, albeit with considerably
different substrate preference. Whereas NTPDase1 hydro-
lyses ATP and ADP about equally well, NTPDase2
preferentially degrades ATP, and NTPDases 3 and 8 reveal
intermediate substrate preferences [12, 13]. In the neural
retina, ADPase enzyme histochemistry and CD39 immuno-
histochemistry allocated NTPDase1 exclusively to the
vasculature [14, 15]. In the brain, NTPDase1 is associated
with microvessels and microglial cells but not with neurons
or astrocytes [16]. NTPDase2 is expressed in the germinal
zones of the developing and adult brain and by subpial
astrocytes [17, 18]. In the peripheral nervous system,
NTPDase1 is expressed by blood vessels and NTPDase2
by various types of glial cells [19]. ENPP1 is an ectoenzyme
with both 5′-nucleotide phosphodiesterase and nucleotide
pyrophosphatase activity [20]. It is expressed in cell lines
derived from brain glial cells and has also been allocated to
brain capillaries and synaptosomal plasma membranes [12,
21–23]. The aim of our study was to investigate whether
extracellular nucleotide metabolism is implicated in the
inhibitory effect of ATP on the osmotic swelling of Müller
cells, to determine the types of ectonucleotidases expressed
by Müller cells and whether the retinal expression of
ectonucleotidases is altered after transient retinal ischaemia
reperfusion.
Materials and methods
Materials
Mitotracker Orange (chloromethyltetramethylrosamine) and
Fluo-4/AM were purchased from Molecular Probes (Eugene,
OR, USA). Adenosine-5′-O-(α,ß-methylene)-diphosphate
(AOPCP), 6-N,N-diethyl-D-ß,γ-dibromomethylene ATP
(ARL-67156), 8-(3-chlorostyryl) caffeine (CSC),
8-cyclopentyl-1,3-dipropylxanthine (DPCPX), N
6-methyl-
2′-deoxyadenosine-3′,5′-bisphosphate (MRS2179), N-
nitrobenzylthioinosine (NBTI), p-nitrophenyl phosphate
(pNPP), pyridoxal-phosphate-6-azophenyl-2′,4′-disulfonic
acid (PPADS), and all other substances used were
obtained from Sigma-Aldrich (Taufkirchen, Germany)
unless stated otherwise. The following antibodies were
used: rabbit anti-NTPDase1 (1:200) [16], rabbit anti-
NTPDase2 (1:500) [17], goat anti-ENPP1 (1:200; Santa
Cruz), goat anti-ecto-5′-nucleotidase (1:200; Santa Cruz),
rabbit anti-P2Y1 (1:100; Alomone), rabbit anti-A1 recep-
tor (1:200; Santa Cruz), mouse anti-vimentin (1:200; V9
clone, Santa Cruz), mouse anti-glutamine synthetase
(1:250, Chemicon) and mouse anti-cellular retinal-
dehyde-binding protein (CRALBP; 1:1000; Acris). The
secondary antibodies were Cy3- conjugated goat anti-
rabbit immunoglobulin (Ig)G (1:400; Dianova), Cy2-coupled
goat anti-mouse IgG (1:200; Dianova), Cy3-coupled donkey
anti-goatIgG(1:200; Dianova)andCy2-coupleddonkeyanti-
mouse IgG (1:200; Dianova).
Animals
All experiments were performed in accordance with the
European Communities Council Directive 86/609/EEC and
were approved by the local authorities. Adult Long-Evans
rats (250–350 g), NTPDase1 (cd39)-deficient mice, and
wild-type mice were used. The generation of NTPDase1-
deficient mice from wild-type animals has been described
previously [24]. Animals had free access to water and food
in an air-conditioned room on a 12-h light–dark cycle.
Transient retinal ischaemia was induced in one eye of the
rats, whereas the other eye remained untreated and served as
control (three animals). Anaesthesia was induced by intra-
muscular ketamine (100 mg/kg) and xylazine(5 mg/kg). The
anterior chamber of the treated eye was cannulated from the
pars plana with a 27-gauge infusion needle connected to a
bag containing normal saline. The intraocular pressure was
increased to 160 mmHg for 60 min by elevating the saline
bag. The animals were killed by carbon dioxide 3 days after
reperfusion, and the eyes were removed.
Müller cell swelling
To determine volume changes of Müller glial cells evoked
by hypotonic stress, the somata of the cells in the inner
nuclear layer of rat retinal slices were recorded. Acutely
isolated slices (thickness, 1 mm) were placed in a perfusion
chamber and loaded with the vital dye Mitotracker Orange
(10 μM). This dye is selectively taken up by Müller
424 Purinergic Signalling (2007) 3:423–433cells, whereas retinal neurons, astrocytes and microglial
cells remain unstained [25]. The stock solution of the
dye was prepared in dimethylsulfoxide and resolved in
saline. The slices were examined with a confocal laser
scanning microscope (LSM) LSM 510 Meta (Zeiss,
Oberkochen, Germany). Mitotracker Orange was excited
at 543 nm, and emission was recorded with a 560 nm
long-pass filter. In the course of the experiments, the
somata of Müller cells were recorded at the plane of their
maximal extension.
A gravity-fed system with multiple reservoirs was
used to perfuse the recording chamber continuously
with extracellular solution; the hypotonic solution and
test substances were added by rapidly changing the
perfusate. The extracellular solution consisted of (mM)
136 NaCl, 3 KCl, 2 CaCl2,1M g C l 2, 10 hydroxyethyl-
piperazine ethanesulfonic acid (HEPES) and 11 glucose,
adjusted to pH 7.4 with Tris. The hypotonic solution (60%
of control osmolarity) was made up by adding distilled
water. Barium chloride was added to the extracellular
solution and was preincubated for 10 min. Blocking
substances were preincubated for 15–45 min, and agonists
were administered simultaneously with the hypotonic
solution.
Calcium imaging
Wholemounts of the rat retina (9 mm
2)w e r ep l a c e di na
perfusion chamber and incubated for 1 h at room temperature
in extracellular solution containing the calcium-sensitive
fluorescence dye Fluo-4/AM (11 μM). After 10 min of
washing by continuous perfusion of extracellular solution,
ATP was added by a fast change of the perfusate. ARL-
67156 was preincubated for 25 min. Fluo-4 was excited at
488 nm; emission was recorded with a band-pass filter
between 505 and 550 nm.
Immunohistochemistry
Isolated rat retinas were fixed in 4% paraformaldehyde for
2 h. After several washing steps in buffered saline, the
tissues were embedded in saline containing 3% agarose
(w/v), and 60-μm-thick slices were cut by using a
vibratome. For double labelling, the slices were incubated
in 5% normal goat or donkey serum plus 0.3% Triton X-
100 in saline for 2 h at room temperature and, subsequently
in a mixture of primary antibodies overnight at 4°C. After
washing in 1% bovine serum albumin, secondary anti-
bodies were administered for 2 h at room temperature.
Control slices were stained without primary antibodies; no
unspecific labelling was observed following incubation
with secondary antibodies (not shown). Images were taken
with the LSM.
Immunocytochemistry
To prepare suspensions of dissociated cells, isolated rat
retinas were stored for 30 min in saline containing 0.4 mg/ml
papain (Boehringer, Mannheim, Germany) at 37°C. After
fixation with 4% paraformaldehyde for 10 min and washing
with saline, the tissues were triturated with a pipette until
single cells were dissociated. The cells were blocked and
permeabilised for 30 min with 5% normal goat serum and
0.3% Triton-X 100, followed by incubation with primary
antibodies for 6 h at 4°C. After washing in 1% bovine serum
albumin in saline, the secondary antibodies were applied for
1 h at room temperature.
Enzyme histochemistry
Mice were deeply anaesthetised with pentobarbital
(800 mg/kg) and perfused intracardially with phosphate-
buffered saline containing heparin (0.5 mg/ml) followed by
0.05 M cacodylate-buffered 4% paraformaldehyde, pH 7.4.
Subsequently, eyes were removed and immersed at 4°C in
the same fixative for 4 h. The eyes were cryoprotected
overnight with 30% sucrose and frozen in isopentane
at −80°C. Frozen tissues were stored at −80°C until
sectioning. Frozen sections (14 μm) were deposited on 3-
aminopropyl-triethoxysilane-coated slides and allowed to
dry for 1 h. The dry sections were stored at −80°C until
further processing. For localisation of ectonucleotidase
activity, a lead phosphate method was applied, as previ-
ously described [16]. In brief, frozen sections were warmed
to room temperature. The enzyme reaction was performed
for 1 h at room temperature in a TMS-buffered substrate
solution (in mM: 2 Pb(NO3)2, 5 MnCl2, 2 CaCl2, 50 Tris-
maleate, pH 7.4, plus 0.25 M sucrose) stabilised with 3%
dextran T 250 (Roth, Karlsruhe, Germany) containing the
substrates ATP, ADP or pNPP (sodium salts; 1 mM each).
In control experiments, the substrate was omitted from the
incubation solution. After washing sections with deminer-
alised water, the lead orthophosphate precipitated as a result
of nucleotidase activity was visualised as a brown deposit
by incubating sections in an aqueous solution of (NH4)2S
(1% v/v).
Data analysis
To determine the extent of swelling of Müller cell somata,
the cross-sectional area of Mitotracker-Orange-stained cell
bodies in the inner nuclear layer of retinal slices was
measured off-line using the analysis software of the LSM.
Bar diagrams display the mean [± standard error of the mean
(SEM)] cross-sectional areas of cell somata that were
measured after 4-min perfusion with hypotonic solution
relative to the somatic area measured before hypotonic
Purinergic Signalling (2007) 3:423–433 425challenge (100%). To evaluate the calcium responses, the
fluorescence of Fluo-4 was normalised to the prestimulus
value by calculation of the ratio F/F0, whereby F0 represents
the baseline fluorescence before agonist application. Statis-
tical analysis was performed using the Prism program
(Graphpad Software, San Diego, CA, USA); significance
was determined by Student’s t test or Kruskal-Wallis test
followed by Dunn’s comparison for multiple groups.
Results
Purinergic signalling inhibits osmotic swelling of Müller
glial cells
To determine whether extracellular nucleotide metabolism is
implicated in the inhibitory effect of ATP on the osmotic
swelling of retinal glial cells, we investigated the alterations
in size of Müller cell somata in acutely isolated rat retina
slices in response to hypotonic stress. As described previ-
ously [26, 27], administration of a hypotonic solution
(containing 60% of control osmolarity) did not alter the
size of Müller cell somata in slices of control retinas,
whereas Müller cell somata swelled in the presence of
barium ions (Fig. 1a,b). Similarly, Müller cell somata in
postischaemic retinas displayed hypotonic swelling. We
recently showed that various purinergic receptor agonists,
such as ATP, ADP and adenosine, inhibit osmotic swelling
of Müller cell somata and that glutamate also inhibits the
swelling via activation of a purinergic signalling cascade
[6]. This signalling cascade is apparently mediated by
autocrine mechanisms in Müller cells, as indicated by the
lack of effect of the blocker of voltage-gated sodium
channels tetrodotoxin on the action of glutamate, ATP and
adenosine (Fig. 1c). The swelling-inhibitory action of
glutamate and ATP were blocked by suramin and the
inhibitor of P2Y and distinct P2X receptors, PPADS
(Fig. 1d). The selective P2Y1 receptor antagonist,
MRS2179, prevented the effects of glutamate and ATP
but not of adenosine (Fig. 1e), whereas the antagonist of
adenosine A1 receptors, DPCPX, prevented the effects of
all three agonists investigated (Fig. 1f). The selective A2a
receptor antagonist, CSC, had no effect (Fig. 1f). The data
suggest that the swelling-inhibitory effects of glutamate and
ATP are mediated by activation of P2Y1 and A1 receptors,
and that the activation of A1 receptors occurs downstream
from P2Y1 receptor activation. Apparently, glutamate
evokes a consecutive release (or formation) of ATP and
adenosine, which successively activates P2Y1 and A1
receptors in Müller cells.
ThoughP2Y1 receptors are suggested to be preferentially
activated by ADP [28], there are also studies that show an
activation by ATP [29, 30]. To determine whether extra-
cellular nucleotide metabolism is involved in the swelling-
inhibitory effect of glutamate, we tested an inhibitor of
ectoapyrases (ARL-67156) and an inhibitor of the ecto-5′-
nucleotidase (AOPCP). The effect of glutamate was
prevented in the presence of ARL-67156 (Fig. 1g), suggest-
ing that glutamate evoked a release of ATP from Müller
cells, which is extracellularly degraded to ADP/adenosine
monophosphate (AMP). On the other hand, AOPCP was
largely ineffective in preventing the effect of glutamate
(Fig. 1G), indicating that the majority of adenosine, which
is released after stimulation with glutamate, is not formed
by extracellular degradation of AMP. Most of the adeno-
sine, which mediates the glutamate effect, is released by
facilitated transport, as indicated by the blocking effect of
the antagonist of nucleoside transporters, NBTI (Fig. 1h).
The data suggest that the swelling-inhibitory effects of
glutamate and ATP involve extracellular degradation of
ATP to ADP but not of AMP into adenosine.
ATP-evoked calcium responses
By rapid degradation, ectonucleotidases are suggested to
limit the actions of purinergic receptor agonists. In rat retina
Müller cells, intracellular calcium responses can be evoked
by various purinergic agonists, such as ATP, ADP and
uridine triphosphate (UTP) [31]. The predominant P2
receptor subtype that evokes calcium responses in rat
Müller cells is the P2Y1 receptor [31]. ATP-evoked calcium
responses in rat Müller cells are restricted to the inner half
of the cells, i.e. to the processes that traverse the inner
plexiform layer, and the cell endfeet at the inner surface of
the retina [6, 32]. To determine whether extracellular
nucleotide metabolism modulates purinergic calcium
responses, we recorded the calcium responses in the endfeet
of Müller cells in acutely isolated retinal wholemounts
upon administration of ATP. ATP-evoked calcium
responses were observed in Müller cell endfeet that
ensheath the ganglion cell bodies, as well as in glial
processes that surround retinal vessels (Fig. 2a). As
purinergic receptor agonists do not evoke P2X receptor-
mediated cation currents in rat Müller cells [33, 34], the
calcium responses are suggested to be evoked by activation
of P2Y receptors. Inhibition of ectoapyrases by ARL-67156
caused a significant increase in the ATP-evoked calcium
responses in the endfeet of Müller cells (Fig. 2b,c). It is
concluded that the activity of ectonucleotidases regulates
the purinergic receptor-mediated calcium responses in
Müller glial cells.
Immunolocalisation of ectonucleotidases
We stained retinal slices and isolated cells to determine the
type of ectonucleotidases expressed by rat Müller cells. In
426 Purinergic Signalling (2007) 3:423–433retinal slices, immunoreactivity for NTPDase1 was pre-
dominantly localised in large blood vessels within the nerve
fibre/ganglion cell layers. In addition, faint staining was
observed in the microvessels of the inner nuclear layer
(arrows in Fig. 3a). Retinal neurons and glial cells, as well
as isolated Müller cells (Fig. 3b), were apparently devoid of
immunoreactivity for NTPDase1. Müller cells express
NTPDase2, as indicated by the glutamine-synthetase-
expressing Müller cell fibres that traverse the inner
plexiform layer in retinal slices (filled arrowheads in
Fig. 3a), and the immunolabeling of isolated Müller cells
(Fig. 3b). The NTPDase2 protein is localised at the whole
plasma membrane of Müller cells, including the membranes
of the cell endfeet and somata. In addition to Müller cell
fibres, NTPDase2 is expressed in both plexiform (synaptic)
layers. Immunoreactivity for ENPP1 was largely absent in
the inner retina, whereas a slight staining of Müller cell
fibres in the outer retina (unfilled arrowheads in Fig. 3a)
was apparent in some (but not all) retinal slices investigat-
ed. Müller cells expressed immunoreactivity for the ecto-5′-
nucleotidase, in particular, at the inner stem processes
(filled arrowheads in Fig. 3a) and endfeet, but also at the
Fig. 1 A purinergic signalling cascade inhibits the osmotic swelling
of Müller glial cells. Rat retina slices were perfused with a hypotonic
solution (60% of control ionic strength), and the cross-sectional area
of Müller cell somata was recorded. In (c–h), retinal slices were
perfused with a hypotonic solution in the presence of barium chloride
(1 mM). a Time-dependent alterations in the soma area of Müller cells
in response to ahypotonic solution. Müller cell somata were recorded in
a control retina in the absence and presence of barium (1 mM) and in a
postischemic retina. Insets: soma of a Müller cell before (left) and
during (right) hypotonic exposure. Bar 5 μm. b Soma area of Müller
cells under hypotonic conditions in control and postischemic retinas.
c Glutamate, adenosine 5′-triphosphate (ATP) and adenosine, respec-
tively, inhibited the hypotonic swelling of Müller cells somata. This
effect remained unaltered in the presence of tetrodotoxin (TTX;1μM).
d Suramin (200 μM) and pyridoxal-phosphate-6-azophenyl-2′,4′-
disulfonic acid (PPADS) (10 μM) prevented the swelling-inhibitory
effects of glutamate and ATP. e The effects of glutamate and ATP (but
not of adenosine) were abolished by the selective blocker of P2Y1
receptors, MRS2179 (30 μM). f The antagonist of adenosine A1
receptors, 8-cyclopentyl-1,3-dipropylxanthine (DPCPX) (100 nM),
prevented the effects of glutamate, ATP and adenosine. The antagonist
of adenosine A2a receptors, 8-(3-chlorostyryl) caffeine (CSC) (200 nM),
did not inhibit theeffect ofadenosine. g The effect of glutamate involves
extracellular metabolism of ATP. The glutamate effect was prevented
by the ectoapyrase inhibitor 6-N,N-diethyl-D-ß,γ-dibromomethylene
ATP (ARL-67156) (50 μM) and remained largely unaltered in the
presence of the ecto-5′-nucleotidase inhibitor, adenosine-5′-O- (α,ß-
methylene)-diphosphate (AOPCP) (250 μM). hThe swelling-inhibitory
effect of glutamate was abolished in the presence of the antagonist of
nucleoside transporters, N-nitrobenzylthioinosine (NBTI) (10 μM).
Agonists were coadministered with the hypotonic solution and tested
at the following concentrations: glutamate, 1 mM; ATP, 10 μM;
adenosine, 10 μM. Bar diagrams display mean ± standard error of the
mean soma areas, which were measured after a 4-min perfusion of the
slices with the hypotonic solution (n=4–16 cells per bar). **P<0.01,
***P<0.001 compared with data obtained before osmotic challenge
(100%).
••P<0.01,
•••P<0.001 compared with data obtained from
swollen cells.
○○P<0.05,
○○○P<0.001 compared with the agonist effects
Purinergic Signalling (2007) 3:423–433 427outer stem processes (Fig. 3b). In addition, neuronal cell
bodies in the ganglion cell and inner nuclear layers may
express immunoreactivity for ecto-5′-nucleotidase (Fig. 3a).
The data suggest that Müller cells express enzymes for the
extracellular degradation of ATP and AMP (NTPDase2 and
ecto-5′-nucleotidase).
We found that the inhibition of osmotic Müller cell
swelling is mediated by the consecutive activation of P2Y1
and adenosine A1 receptors (see above). Müller cells
express the immunoreactivities for both receptor proteins,
which is indicated by the staining of vimentin-positive
Müller cell fibres in the inner plexiform layer (filled
arrowheads in Fig. 3a). In addition, neuronal cell bodies
in the inner nuclear and ganglion cell layers apparently
express immunoreactivities for P2Y1 and A1 receptors
(Fig. 3a). Induction of osmotic swelling is a characteristic
feature of Müller cells after transient retinal ischaemia
(Fig. 1a,b) [26], which can be inhibited by activation of the
purinergic signalling cascade described above [6]. We
stained retinal slices that were obtained 3 days after
transient retinal ischaemia and found no alteration in the
overall localisation of the various enzyme and receptor
proteins investigated (Fig. 3c and not shown). An apparent
upregulation of the immunoreactivities in the inner retina
[ganglion cell layer (GCL), inner plexiform layer (IPL),
inner nuclear layer (INL)] may be caused by the strong
decrease in thickness of the inner retinal layers (in
particular, of the IPL), which is a typical degeneration
pattern of rodent retinas after transient ischemia.
Ectonucleotidase histochemistry
To further identify the nature of retinal ectonucleotidases,
we analysed retinal tissues of NTPDase1-deficient and
wild-type mice using enzyme histochemistry. When ATP
was used as substrate, histochemical staining was observed
throughout the retinal tissue of both wild-type and
knockout mice, with preferential reaction deposit in the
outer retina (Fig. 4a). This suggests that deletion of the
NTPDase1 gene has no significant effect on ATPase
activity in the retina. Even though the resolution of the
enzyme histochemical images is limited due to dispersion
of the reaction product, they correspond closely to the
immunostaining for NTPDase2 in the rat retina, except that
blood vessels are stained in addition (Fig. 3a). In contrast,
when ADP was applied as substrate in wild-type mouse
retinas for the same length of time as ATP, staining of the
retinal parenchyma was largely abolished. However, strong
staining of the vessels was maintained (Fig. 4b). This
pattern of enzyme histochemical staining was very similar
to the immunohistochemical staining for NTPDase1
(Fig. 3a). The enzyme histochemical staining at blood
vessels for ADP was abolished in retinas of NTPDase1-
deficient mice (Fig. 4b). No staining of the neural retina was
observed when pNPP was applied as a substrate of alkaline
phosphatase (Fig. 4c). The pigment epithelium of both
wild-type and knockout mice was strongly stained with all
substrates used, suggesting that it is rich in nonspecific
phosphatases (alkaline phosphatase). No reaction product
Fig. 2 Extracellular nucleotide metabolism modulates the adenosine 5′-
triphosphate (ATP)-evoked calcium responses in rat retina Müller cell
endfeet. a Views onto the nerve fibre/ganglion cell layers of a retinal
wholemount. The images show the fluorescence of Fluo-4 and were
taken before (control) and during the peak calcium response upon bath
appplication of ATP (50 μM). Asterisk, retinal vein. Arrow, capillary.
Arrowhead, nerve fibre bundles. Bar 20 μm. b Time-dependent changes
of the relative fluorescence ratio in Müller cell endfeet. The ATP
(10 μM)-evoked responses were recorded in the absence (control) and
presence of 6-N,N-diethyl-D-ß,γ-dibromomethylene ATP (ARL-67156)
(50 μM). A fluorescence ratio of one means no change in the cytosolic
free calcium level. c Mean (± standard error of the mean) amplitude of
the ATP (10 μM)-evoked calcium responses (n=38 and 50 endfeet per
bar). *P<0.05 compared with the ATP control
Fig. 3 Immunohistochemical localisation of ectonucleotidases and
purinergic receptors in rat retina Müller glial cells. a Retinal slices. b
Isolated Müller cells. c Slices of postischemic retinas that were
obtained from animals 3 days after transient retinal ischemia. The
tissues and cells were coimmunostained against the glial-cell-specific
proteins vimentin, glutamine synthetase or mouse anti-cellular
retinaldehyde-binding protein (CRALBP). Filled arrows, blood
vessels. Filled arrowheads, Müller cell fibres in the inner nuclear
layer (INL). Unfilled arrows, Müller cell endfeet. Unfilled arrow-
heads, a, c Müller cell fibres in the outer nuclear layer (ONL) and
b Müller cell somata, respectively. GCL ganglion cell layer, IPL inner
plexiform layer, PRS photoreceptor segments. Bars 20 μm

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data suggest that NTPDase2 (that has a very high
preference for ATP as a substrate, ATP to ADP hydrolysis
ratio of ∼10:1 [35]), is the major ATP-degrading ectonu-
cleotidase of the neural retina, where it is associated with
Müller cells. NTPDase1 (that equally hydrolyses ATP and
ADP) is restricted to blood vessels, and activity of alkaline
phosphatase at physiological pH is essentially absent. The
lack of enzyme histochemical staining for ecto-ADPase in
the NTPDase1 knockout mice (Fig. 4b) also suggests the
absence of NTPDase3 and NTPDase8.
Discussion
The data presented here suggest that extracellular ATP
metabolism is involved in the autocrine regulation of the
Müller cell volume in response to osmotic stress. Obvious-
ly, there is a multilevel signalling cascade resulting in a
prevention of cellular swelling under hypoosmotic stress.
Whereas we focused on the role of ectonucleotidases in this
study, other aspects of this cascade were described in a
previous study [6]. One of the first steps is the release of
glutamate by retinal neurons, which activates metabotropic
glutamate receptors on Müller glial cells [6]. Because a
blockade of neuronal activity by tetrodotoxin did not
abolish the effect of glutamate, we concluded that neurons
are not involved in the cascade downstream from activation
of metabotropic glutamate receptors. The pharmacological
data presented in Fig. 1 suggest the further course of the
cascade. Activation of glial metabotropic glutamate recep-
tors evokes a release of ATP, which is assumed to be
metabolised to ADP. This assumption is supported by the
finding that the inhibitor of ectoapyrases, ARL-67156,
Fig. 4 Enzyme histochemical
localisation of ectonucleotidase
activity in retinal slices of nu-
cleoside triphosphate diphos-
phohydrolases (NTPDase1)
wild-type (cd39+/+) and
NTPDase1-deficient (cd39−/−)
mice. a When adenosine 5′-
triphosphate (ATP) is used as
substrate, the reaction product is
distributed throughout the reti-
nal tissue, with most intense
staining in the outer plexiform
layer. b The use of adenosine 5′-
diphosphate (ADP) as substrate
results in a staining of retinal
blood vessels (arrows). This
staining is lost in NTPDase1-
deficient mice. c p-nitrophenyl
phosphate (pNPP), a substrate of
alkaline phosphatase, reveals no
retinal staining except of the
pigment epithelium. The pig-
ment epithelium has been lost in
some sections. GCL ganglion
cell layer, INL inner nuclear
layer, IPL inner plexiform layer,
ONL outer nuclear layer, PRS
photoreceptor segments. Bars
20 μm
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(Fig. 1g). In addition to the unspecific blockers of P2
receptors, suramin and PPADS, the P2Y1-specific inhibitor,
MRS2179, efficiently suppressed the effects of glutamate
and ATP, suggesting that ADP resulting from the action of
ectoapyrases activates P2Y1 receptors on Müller cells.
Expression of this receptor subtype on rat Müller cells
was demonstrated previously [31, 36]. The further degra-
dation of ADP to AMP and adenosine does not play a
decisive role in the cascade because the blocker of ecto-5′-
nucleotidases, AOPCP, reduced the glutamate effect non-
significantly. However, adenosine is obviously involved in
the cascade. Whereas inhibition of P2Y1 prevented the
effects of glutamate and ATP, it did not alter the action of
adenosine. Thus, the effect of adenosine is an event
downstream from the activation of glutamate and P2Y1
receptors. Using two different subtype-specific adenosine
receptor blockers, we concluded that the adenosine effect is
mediated by activation of A1 receptors (Fig. 1f). Because
extracellular formation of adenosine is likely to be only a
minor source of this nucleoside, the blocker of nucleoside
transporters, NBTI, was tested and prevented the effect of
glutamate. This suggests that the main part of adenosine is
liberated via a transporter. We did not investigate the final
steps of the cascade downstream from the activation of A1
receptors. It was concluded from previous data [6, 37] that
activation of A1 receptors causes the opening of potassium
and chloride channels in the Müller cell membrane; thus,
the cells extrude potassium and chloride ions, which is
associated with a water efflux that prevents swelling under
hypoosmotic conditions. Considering the results presented
in this study, the extracellular enzymatic degradation of
ATP to ADP might play a crucial role in the purinergic
cascade involved in the autocrine regulation of the Müller
cell volume.
The activity of ectonucleotidases controls the level of
purinergic receptor agonists in the extracellular space. We
found that inhibition of ectoapyrases increased the ATP-
evoked calcium responses in Müller cell endfeet, suggest-
ing that ectonucleotidases control the availability of
extracellular ATP that evokes calcium responses predomi-
nantly by activation of P2Y1 receptors [31]. The relatively
small effect of the ectoapyrase inhibitor may be explained
by the possibility that ATP-evoked ATP release from
Müller cells may overwhelm the extracellular degradation
of ATP. By rapid inactivation of purinergic signalling,
ectonucleotidases may regulate the light-evoked purinergic
neuron-to-glia signalling in the retina [32] and the long-
range purinergic calcium signalling in the network of retinal
glial cells [4].
In a third step of the study, we investigated the
expression of enzymes involved in extracellular nucleotide
degradation in Müller cells. We found that Müller cells of
the rat express immunoreactivities for NTPDase2 and ecto-
5′-nucleotidase but not for NTPDase1 and only faintly for
ENPP1. The expression of ecto-5′-nucleotidase is in
agreement with previous studies [7–9]. The expression of
NTPDase2 by Müller cells is a novel finding and is in
agreement with data that showed an expression of NTPDase2
(but not NTPDase1) in distinct glial cells of the brain and
peripheral nervous system [16, 17, 19], as well as with a
recent study that described a localisation of ecto-ATPase
activity at the electron microscopic level in Müller cell
membranes (in addition to synaptic membranes) [38]. The
enzyme histochemical experiments revealed that NTPDase2
is the major ATP-degrading ectonucleotidase of the neural
mouse retina, whereas NTPDase1 activity is restricted to
blood vessels and alkaline phosphatase is essentially absent
at physiological pH. The data also rule out the possibility of
a significant expression of NTPDases 3 and 8 in the retinal
parenchyma. Our data confirm previous studies describing
an exclusive localisation of NTPDase1-like activity and
protein to the vasculature of the neural retina [14, 15].
According to our data, ATP can be rapidly hydrolysed within
the retinal parenchyma, whereas (due to the very low
ADPase activity of NTPDase2) ADP will be degraded with
a considerable delay. The retinal pigment epithelium appar-
ently expresses the activity of nonspecific phosphatases
(alkaline phosphatase) and may also express various other
extracellular nucleotide-degradative enzymes [39].
The enzyme histochemical data are in agreement with
the results of the cell-swelling experiments indicating that
ecto-5′-nucleotidase activity is not involved in the regula-
tion of Müller cell volume, likely due to the absence of the
substrate AMP. The small, nonsignificant effect of the 5′-
nucleotidase inhibitor (Fig. 1g) may reflect the very slow
and delayed degradation of ADP to AMP by NTPDase2
[35]. However, further investigations are necessary to
confirm the involvement of extracellular nucleotide metab-
olism in the regulation of Müller cell volume. The
nucleotide analogue ARL-67156 has been suggested to
inhibit the activities of ectoapyrases in several tissues [40–
42]. A recent study using a capillary electrophoresis
enzyme assay has shown that ARL-67156 blocks predom-
inantly the activity of recombinant NTPDases1 and 3 and
has only a minor effect on the activity of recombinant
NTPDase2 [43]. Our experimental data imply that
NTPDase2 was inhibited by ARL-67156 in retinal slices.
It remains to be determined whether the functional state of
NTPDase2 (such as its oligomeric state [35]) can govern its
sensitivity to certain inhibitors or whether ARL-67156 may
exert additional effects in intact tissues in situ, such as a
blockade of the release of ATP from agonist-stimulated
cells [44].
Both extracellular degradation of ATP and the formation
of adenosine have been implicated in the suppression of
Purinergic Signalling (2007) 3:423–433 431neuronal activity in the retina [5]. It has been suggested that
ATP released from Müller cells is converted extracellularly
to adenosine, which in turn activates A1 receptors in a
subset of retinal ganglion cells, resulting in cellular hyper-
polarisation [5]. The present results indicate that both
neuronal cells and Müller cells express ecto-5′-nucleotidase,
that forms adenosine from AMP. On the other hand, we
found that only the activity of ecto-ATPases (and not of the
ecto-5′-nucleotidase) is implicated in the regulation of Müller
cell volume and that comparable ecto-ADPase activity
(which may deliver AMP as the substrate of ecto-5′-
nucleotidase) is absent from the retinal parenchyma. The
reason for the discrepancy with previously published data [5]
is unclear and remains to be solved in future investigations.
It cannot be ruled out that pharmacological modulation of the
glial purinergic signalling may also indirectly alter neuronal
activity via alterations of the glial cell volume and, therefore,
of the extracellular space volume. Moreover, differences in
the local microenvironment and the spatial relationship of
ectonucleotidases, purinergic receptors and transporter mol-
ecules may explain some of the different findings.
In summary, we found that NTPDase2 is the major ATP-
degradative ectonucleotidase in the parenchyma of rodent
retinas, whereas NTPDase1 is expressed solely in retinal
vessels. The activity of NTPDase2 is suggested to be
implicated in the regulation of the Müller cell volume under
osmotic stress conditions. This regulation is likely mediated
by extracellular degradation of released ATP and subsequent
transporter-mediated release of adenosine. The activity of
NTPDase2 is also involved in the regulation of ATP-evoked
calcium responses in Müller cells; this may have functional
importance for the purinergic neuron-to-glia signalling
observed in response to light stimulation [32]. Additional
investigations are required to determine the functional roles
of NTPDase2 and ecto-5′-nucleotidase in the reciprocal
signalling between neurons and glia in the retina.
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